Navigation Links
Kantar Health CEO to Participate in Panel Discussion at PMRG 2010 Annual National Conference
Date:3/11/2010

NEW YORK, March 11 /PRNewswire/ -- Kantar Health, a leading healthcare-focused global consultancy and marketing insights company, today announced that Chief Executive Officer Lynnette Cooke will participate in a panel discussion at the Pharmaceutical Marketing Research Group's (PMRG) 2010 Annual National Conference. The conference will take place March 21-23, 2010, at Disney's Contemporary Resort in Orlando, Florida.

Ms. Cooke and other leaders from marketing research agencies will comment on the fundamental changes they saw in their businesses in 2009, trends they are observing in 2010, and predictions for the future. Topics will include:

  • Relationships between clients and agencies
  • An exploration of new methodologies
  • Regulatory issues and their impact on marketing research
  • The new reality in a highly competitive marketplace

"The worldwide economy and regulatory issues continue to cast uncertainty over the pharmaceuticals industry," Ms. Cooke said. "In keeping with the conference theme -- 'Waves of Change: Preparing Wisely for Healthcare's Uncertain Future' -- we hope the discussion will provide participants with a better understanding of industry trends and challenges and how companies such as Kantar Health can help them successfully adapt to the changing industry."

Prior to Kantar Health, Ms. Cooke was CEO of Kantar Health legacy company the Ziment Group, which included Ziment, Consumer Health Sciences and All Global. Throughout her career, she has held senior positions in research and product management. Her marketing research background spans a broad range of industries: pharmaceutical and medical/surgical, consumer packaged goods, financial services, and child and family products.

The roundtable discussion, "CEO Reflections on a Tumultuous Year and Predictions for an Uncertain Future," will begin at 10:45 am on Monday, March 22. Kantar Health is a sponsor of the PMRG 2010 Annual National Conference. For more information, please visit the conference's website.

About Kantar Health

Kantar Health is a leading healthcare-focused global consultancy, specializing in portfolio optimization, market access, safety and outcomes, and brand and customer insights. Formed by uniting Consumer Health Sciences, MattsonJack, TNS Healthcare and Ziment, it is the next-generation decision support partner to the pharmaceutical and biotech industries, delivering evidence-based guidance to support clients' global and local success.

With 40+ offices throughout the Americas, Europe, Asia-Pacific, the Middle East and Africa, Kantar Health provides the broadest global footprint, coupled with the strongest local knowledge to help drive clients' maximum performance in every geography. Market-leading solutions ensure optimal decisions and actions across the brand life cycle, from assessing opportunities and sizing markets...to developing products and building access strategies...to positioning brands and creating messaging...to managing stakeholder relationships and monitoring treatment outcomes.

SOURCE Kantar Health

Back to top

RELATED LINKS
http://www.kantarhealth.com

'/>"/>

SOURCE Kantar Health
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Kantar Health Oncology Thought Leaders to Present at Upcoming Industry Meetings
2. Kantar Health and ImpactRx Launch CancerMPact Monthly Drugs and Regimens for Oncology Business Decisions
3. CVS Caremark to Present at the Barclays Capital 2010 Global Healthcare Conference
4. Cornerstone Therapeutics to Present at the 30th Annual Cowen & Company Health Care Conference
5. U.S. Surgeon General Dr. Regina M. Benjamin to Deliver Commencement Address at Albany College of Pharmacy and Health Sciences
6. Limited Healthcare Infrastructure and Weak Intellectual Property Protection are Among the Challenges Pharma Faces with Emerging Market Expansion
7. Feintuch Communications Launches Integrated PR and IR Practice for Healthcare and Life Sciences Organizations
8. Genomic Health Announces Publication of Study Using Oncotype DX(R) in Node-Negative and Node-Positive Breast Cancer Patients Treated With Aromatase Inhibitors
9. Neurocrine Biosciences to Present at the 30th Annual Cowen & Co. Health Care Conference
10. NOVAVAX to Present at Cowen and Companys 30th Annual Health Care Conference
11. RoundTable Healthcare Partners Names Charles W. Stiefel as Senior Advisor
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/19/2017)... 19, 2017 Global Prostate Cancer Therapeutics ... the prostate cancer therapeutics market analyzes the current ... prevalence of prostate cancer, launch of promising emerging ... of new drugs & therapeutic biological products, and ... to lesser side effects are some of the ...
(Date:4/19/2017)... The Global Effective Microorganisms (EM) Market by Manufacturers, ... and analysed the potential of Global Effective Microorganisms (EM) Market ... growth factors. The report identifies and analyses the emerging trends ... market. ... and Figures, 6 Major Company Profiles, spread across 124 pages ...
(Date:4/19/2017)... Companion animal vaccines ... pets such as canine, avian and feline. ... such as Attenuated Live Vaccines, Conjugate Vaccines, Inactivated ... Recombinant Vaccines. Attenuated live vaccines are derived from ... have been weakend under laboratory conditions. Conjugate vaccines ...
Breaking Medicine Technology:
(Date:4/28/2017)... ... April 28, 2017 , ... Somnoware, a leading provider ... Online(TM), which enables sleep physicians to create and edit their interpretation reports. This ... provides a familiar interface that does not require additional training to use. It ...
(Date:4/28/2017)... NY (PRWEB) , ... April 28, 2017 , ... ... Laboratory to expanded distribution of the GlycoMark test throughout the Northeast U.S. ... hyperglycemia in patients with diabetes. The GlycoMark test provides a clinically proven one- ...
(Date:4/28/2017)... york (PRWEB) , ... April 28, 2017 , ... ... to announce that Aditya Patel M.D. has joined the revolutionary endoscopic practice under ... and board certification in Interventional Pain Medicine. The patented, revolutionary eDiscSculpt Technique created ...
(Date:4/28/2017)... ... April 28, 2017 , ... Early detection and ... drug safety and minimize the cost of development. In this webinar, sponsored by ... cell lines and for cardiac toxicity using induced pluripotent stem cells (iPSCs). , ...
(Date:4/28/2017)... ... April 28, 2017 , ... Researchers at ... ActiGraph’s CentrePoint Data Hub in a sample of participants enrolled in ... activity and sleep monitoring solutions for the global scientific community. The company’s new ...
Breaking Medicine News(10 mins):